Healthcare provider profile · identity verified

John E Franklin, Jr., M.D.

Internal Medicine · CHARLOTTE, NC · NPI 1679639686

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1666	745
Levothyroxine Sodium	Levothyroxine Sodium	1105	482
Amlodipine Besylate	Amlodipine Besylate	712	305
Lisinopril	Lisinopril	656	301
Losartan Potassium	Losartan Potassium	573	263
Gabapentin	Gabapentin	426	164
Rosuvastatin Calcium	Rosuvastatin Calcium	404	177
Hydrochlorothiazide	Hydrochlorothiazide	349	155
Omeprazole	Omeprazole	347	156
Simvastatin	Simvastatin	318	138
Metoprolol Succinate	Metoprolol Succinate	316	147
Metformin Hcl	Metformin Hcl	307	142
Trazodone Hcl	Trazodone Hcl	278	141
Escitalopram Oxalate	Escitalopram Oxalate	268	125
Alendronate Sodium	Alendronate Sodium	236	86
Pantoprazole Sodium	Pantoprazole Sodium	226	100
Tamsulosin Hcl	Tamsulosin Hcl	220	101
Allopurinol	Allopurinol	178	78
Albuterol Sulfate Hfa	Albuterol Sulfate	171	71
Eliquis	Apixaban	165	67
Pravastatin Sodium	Pravastatin Sodium	164	71
Sertraline Hcl	Sertraline Hcl	158	69
Synthroid	Levothyroxine Sodium	155	65
Celecoxib	Celecoxib	136	48
Metformin Hcl Er	Metformin Hcl	130	67
Bupropion Xl	Bupropion Hcl	125	61
Montelukast Sodium	Montelukast Sodium	124	57
Atenolol	Atenolol	117	50
Jardiance	Empagliflozin	117	35
Famotidine	Famotidine	116	49
Potassium Chloride	Potassium Chloride	114	57
Furosemide	Furosemide	112	52
Duloxetine Hcl	Duloxetine Hcl	107	45
Citalopram Hbr	Citalopram Hydrobromide	103	49
Fluticasone Propionate	Fluticasone Propionate	100	49
Estradiol	Estradiol	98	55
Ozempic	Semaglutide	98	32
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	97	39
Ezetimibe	Ezetimibe	92	43
Spironolactone	Spironolactone	89	42
Donepezil Hcl	Donepezil Hcl	86	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	32
Fluoxetine Hcl	Fluoxetine Hcl	78	35
Metoprolol Tartrate	Metoprolol Tartrate	77	35
Valacyclovir	Valacyclovir Hcl	76	48
Mirtazapine	Mirtazapine	74	33
Clopidogrel	Clopidogrel Bisulfate	73	34
Finasteride	Finasteride	70	32
Quetiapine Fumarate	Quetiapine Fumarate	67	22
Zolpidem Tartrate	Zolpidem Tartrate	66	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	26
Valsartan	Valsartan	62	25
Diclofenac Sodium	Diclofenac Sodium	59	25
Meloxicam	Meloxicam	59	29
Venlafaxine Hcl Er	Venlafaxine Hcl	57	25
Acyclovir	Acyclovir	56	33
Propranolol Hcl	Propranolol Hcl	56	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	54	52
Olmesartan Medoxomil	Olmesartan Medoxomil	53	24
Paroxetine Hcl	Paroxetine Hcl	53	25
Carvedilol	Carvedilol	52	27
Lovastatin	Lovastatin	50	22
Trulicity	Dulaglutide	49	15
Rizatriptan	Rizatriptan Benzoate	45	14
Benazepril Hcl	Benazepril Hcl	43	21
Oxybutynin Chloride Er	Oxybutynin Chloride	41	20
Xarelto	Rivaroxaban	41	19
Bupropion Hcl Sr	Bupropion Hcl	38	20
Buspirone Hcl	Buspirone Hcl	38	20
Ipratropium Bromide	Ipratropium Bromide	38	18
Januvia	Sitagliptin Phosphate	38	23
Lorazepam	Lorazepam	38	23
Myrbetriq	Mirabegron	38	13
Ibuprofen	Ibuprofen	37	18
Chlorthalidone	Chlorthalidone	34	17
Irbesartan	Irbesartan	33	13
Memantine Hcl	Memantine Hcl	33	11
Baclofen	Baclofen	31	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	13
Symbicort	Budesonide/Formoterol Fumarate	31	15
Glipizide Er	Glipizide	29	11
Latanoprost	Latanoprost	29	11
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	12
Enalapril Maleate	Enalapril Maleate	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	15
Terazosin Hcl	Terazosin Hcl	26	13
Febuxostat	Febuxostat	24	suppressed
Naproxen	Naproxen	24	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Ramipril	Ramipril	23	14
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	15
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	14
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Bupropion Hcl	Bupropion Hcl	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	11
Topiramate	Topiramate	20	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Minoxidil	Minoxidil	19	suppressed
Prednisone	Prednisone	19	14
Primidone	Primidone	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Glipizide	Glipizide	18	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Colchicine	Colchicine	17	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Pregabalin	Pregabalin	16	suppressed
Progesterone	Progesterone, Micronized	16	11
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Risedronate Sodium	Risedronate Sodium	14	suppressed
Felodipine Er	Felodipine	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Alprazolam	Alprazolam	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Digoxin	Digoxin	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Indomethacin	Indomethacin	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nadolol	Nadolol	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Tramadol Hcl	Tramadol Hcl	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error